Skip to content
Politically.com Search all
Menu

2026 · 3rd Quarter (July 1 - Sep 30)

IONIS PHARMACEUTICALS, INC.

Filed by LMH STRATEGIC SOLUTIONS.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-10-28 06:26:13 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 19, 2026
Income
$30,000.00
Expenses
Not reported
Filing UUID
435a9c84-df39-4bb6-86c8-4f49639e54af
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Pediatric Review Reauthorization. H.R.946/S.1862: ORPHAN Cures Act. H.R.1672: Maintaining Investments in New Innovation (MINI) Act. H.R.1262/S.932: Give Kids a Chance Act of 2025.

Literal federal measure citations: H.R.946, S.1862, H.R.1672, H.R.1262, S.932

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.